Abstract #120: Prospective tractography-aided VIM targeting during HIFU: long-term outcomes

Introduction: Focused ultrasound thalamotomy (FUS-T) is an FDA approved for the treatment of Essential Tremor (ET). We have previously reported improved safety by prospectively identifying the ventral intermediate nucleus (VIM) using tractography thus reducing the need for extensive mapping. The durability of tremor improvement with this approach is unknown. Here we report for the first time the outcomes up to two years in a cohort of 9 patients with essential tremor who underwent FUS-T as a part of the FDA continued access trial.

Source: BRAIN STIMULATION: Basic, Translational, and Clinical Research in Neuromodulation - January 22, 2019 Category: Neurology Authors: Francesco Sammartino, Punit Agrawal, Barbara Changizi, Eric C. Bourekas, Michael V. Knopp, Ali Rezai, Vibhor Krishna Source Type: research